Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Angiodynamics (ANGO) Other Non Operating Income (2016 - 2026)

Angiodynamics' Other Non Operating Income history spans 17 years, with the latest figure at $5.0 million for Q1 2026.

  • For Q1 2026, Other Non Operating Income fell 8.53% year-over-year to $5.0 million; the TTM value through Feb 2026 reached $4.3 million, down 13.45%, while the annual FY2025 figure was $4.9 million, 705.14% up from the prior year.
  • Other Non Operating Income reached $5.0 million in Q1 2026 per ANGO's latest filing, up from -$128000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $5.4 million in Q1 2025 to a low of -$325000.0 in Q2 2025.
  • Average Other Non Operating Income over 5 years is $487875.0, with a median of -$174000.0 recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: tumbled 2420.0% in 2022, then surged 2381.51% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$252000.0 in 2022, then surged by 87.3% to -$32000.0 in 2023, then soared by 137.5% to $12000.0 in 2024, then plummeted by 1166.67% to -$128000.0 in 2025, then soared by 3980.47% to $5.0 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Other Non Operating Income are $5.0 million (Q1 2026), -$128000.0 (Q4 2025), and -$178000.0 (Q3 2025).